Simply Wall St.
Does Autolus Therapeutics (AUTL) Pairing AUCATZYL Approvals With Revenue Guidance Redefine Its Long-Term Story?
📈
AI Sentiment
Highly Positive
8/10
Autolus Therapeutics plc News
Latest updates and market news for AUTL
7 news
Jan 12 - Jan 18, 2026
Page 1
MT Newswires
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Tuesday Trading
âž–
AI Sentiment
Neutral
5/10
MT Newswires
Truist Adjusts Price Target on Autolus Therapeutics to $8 From $10, Maintains Buy Rating
📊
AI Sentiment
Positive
7/10
MT Newswires
Truist Cuts Price Target on Autolus Therapeutics to $8 From $10, Keeps Buy Rating
📊
AI Sentiment
Positive
7/10
Simply Wall St.
Autolus Therapeutics (AUTL) Valuation Check After Revenue Guidance And AUCATZYL UK And EU Approvals
âž–
AI Sentiment
Neutral
4/10
MT Newswires
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading
📊
AI Sentiment
Positive
6/10
GlobeNewswire
Autolus Therapeutics Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Net Product Revenue, Pipeline Advancements and Outlook for 2026
📈
AI Sentiment
Highly Positive
9/10
Share this news page